Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 570.96 USD 1.36% Market Closed
Market Cap: 8.6B USD
Have any thoughts about
Chemed Corp?
Write Note

Chemed Corp
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemed Corp
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Chemed Corp
NYSE:CHE
Income from Continuing Operations
$301.7m
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
13%
DaVita Inc
NYSE:DVA
Income from Continuing Operations
$1.1B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
3%
Quest Diagnostics Inc
NYSE:DGX
Income from Continuing Operations
$868m
CAGR 3-Years
-26%
CAGR 5-Years
4%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Income from Continuing Operations
$5B
CAGR 3-Years
-13%
CAGR 5-Years
3%
CAGR 10-Years
1%
Cigna Corp
NYSE:CI
Income from Continuing Operations
$3.3B
CAGR 3-Years
-26%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Laboratory Corporation of America Holdings
NYSE:LH
Income from Continuing Operations
$436.7m
CAGR 3-Years
-46%
CAGR 5-Years
-11%
CAGR 10-Years
-2%
No Stocks Found

Chemed Corp
Glance View

Market Cap
8.6B USD
Industry
Health Care

Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division positions the company well within the rapidly expanding home healthcare market, facilitating personalized care in a familiar environment, which has shown significant promise in improving patient outcomes. For investors, Chemed Corp. offers a compelling investment narrative characterized by steady growth, financial stability, and a robust operational model. The company has demonstrated strong revenue generation and consistently high margins, reflective of its effective management and operational efficiencies. With a solid balance sheet and commitment to shareholder returns, Chemed has a track record of delivering value through dividends and strategic reinvestments. Moreover, as healthcare policies increasingly favor in-home care solutions and as demographics shift towards an older population, Chemed is poised to capture considerable market opportunities. Its proven ability to adapt to changing healthcare needs not only underlines its resilience but also highlights its potential for sustained financial performance and long-term growth.

CHE Intrinsic Value
503.31 USD
Overvaluation 12%
Intrinsic Value
Price

See Also

What is Chemed Corp's Income from Continuing Operations?
Income from Continuing Operations
301.7m USD

Based on the financial report for Sep 30, 2024, Chemed Corp's Income from Continuing Operations amounts to 301.7m USD.

What is Chemed Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
13%

Over the last year, the Income from Continuing Operations growth was 23%. The average annual Income from Continuing Operations growth rates for Chemed Corp have been -1% over the past three years , 8% over the past five years , and 13% over the past ten years .

Back to Top